人类表面活性蛋白B变体对铜绿假单胞菌肺炎诱导脓毒症遗传易感性的调控作用
该研究用野生型FVB/NJ小鼠和表达人类SP-B C或T等位基因的人源化转基因小鼠(无小鼠SP-B基因),经气管内感染50 μL(4×10 CFUs/鼠)铜绿假单胞菌Xen5或生理盐水,于感染后24或48小时处死,用活体成像监测0至48小时细菌动态生长,并分析肺组织和支气管肺泡灌洗液的病理、细胞和分子变化,用约束液滴表面张力测定法测定表面活性剂表面张力。结果显示SP-B-C小鼠较SP-B-T或野生型 Bioluminescence和CFUs更高、炎症和死亡率增加、肺损伤评分更高、II型细胞板层体减少(P<0.05);感染小鼠最低表面张力显著升高(P<0.01),顺序为SP-B-C > SP-B-T > 野生型;SP-B-C感染肺内多种细胞因子水平高于SP-B-T和野生型(P<0.01);SP-B-C还表现为SP-B更低、NF-κB和NLRP3炎症小体活化更高、活化caspase-3更高。结论认为人类SP-B变体通过调节表面活性剂表面活性、细胞死亡和炎症信号通路差异调控脓毒症易感性。
要点
- 在铜绿假单胞菌肺炎诱导脓毒症小鼠模型中,表达人类SP-B C等位基因的小鼠较表达T等位基因或野生型小鼠细菌负荷更高、炎症更重、死亡率更高(P<0.05)。
- SP-B-C小鼠肺损伤评分更高、II型细胞板层体数量更少,感染后最低表面张力升高顺序为SP-B-C > SP-B-T > 野生型(P<0.01)。
- SP-B-C感染肺内多种细胞因子水平高于SP-B-T和野生型(P<0.01),且SP-B更低、NF-κB和NLRP3炎症小体活化更高、活化caspase-3更高。
- 该研究为动物实验,结果提示人类SP-B rs1130866变体可能差异调控脓毒症易感性,尚不能直接用于临床决策。
适用人群与场景
- 野生型FVB/NJ小鼠和人源化转基因SP-B-T、SP-B-C小鼠(表达人类SP-B C或T等位基因且无小鼠SP-B基因),经气管内感染铜绿假单胞菌Xen5或生理盐水。
研究设计与关键结果
- 研究类型为动物实验,比较野生型FVB/NJ小鼠与人源化转基因SP-B-T和SP-B-C小鼠经气管内感染50 μL(4×10 CFUs/鼠)铜绿假单胞菌Xen5或生理盐水后24或48小时的变化。
- SP-B-C小鼠较SP-B-T或野生型小鼠生物发光信号和CFUs更高、炎症和死亡率增加、肺损伤评分更高、II型细胞板层体数量减少(P<0.05)。
- 感染小鼠最低表面张力显著升高(P<0.01),升高程度顺序为SP-B-C > SP-B-T > 野生型。
- 感染SP-B-C小鼠肺内多种细胞因子水平高于SP-B-T和野生型(P<0.01)。
- SP-B-C较SP-B-T或野生型表现出更低的SP-B、更高的NF-κB和NLRP3炎症小体活化以及更高的活化caspase-3。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为小鼠动物实验,结果提示人类SP-B rs1130866 C等位基因可能通过调节表面活性剂表面活性、细胞死亡和炎症信号通路增加对铜绿假单胞菌肺炎诱导脓毒症的易感性,尚不能直接改变急诊或ICU床旁实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Surfactant protein B (SP-B) is essential for life and plays critical roles in host defense and lowering alveolar surface tension. A single-nucleotide polymorphism (SNP rs1130866) of human SP-B (hSP-B) alters the N-linked glycosylation, thus presumably affecting SP-B function. This study has investigated the regulatory roles of hSP-B genetic variants on lung injury in pneumonia-induced sepsis.
METHODS: Wild-type (WT) FVB/NJ and humanized transgenic SP-B-T and SP-B-C mice (expressing either hSP-B C or T allele without mouse SP-B gene) were infected intratracheally with 50 μL (4 × 10 colony-forming units [CFUs]/mouse) Pseudomonas aeruginosa Xen5 or saline, and then killed 24 or 48 h after infection. Bacterial dynamic growths were monitored from 0 to 48 h postinfection by in vivo imaging. Histopathological, cellular, and molecular changes of lung tissues and bronchoalveolar lavage fluid (BALF) were analyzed. Surface tension of surfactants was determined with constrained drop surfactometry.
RESULTS: SP-B-C mice showed higher bioluminescence and CFUs, increased inflammation and mortality, the higher score of lung injury, and reduced numbers of lamellar bodies in type II cells compared with SP-B-T or WT (P < 0.05). Minimum surface tension increased dramatically in infected mice (P < 0.01) with the order of SP-B-C > SP-B-T > WT. Levels of multiple cytokines in the lung of infected SP-B-C were higher than those of SP-B-T and WT (P < 0.01). Furthermore, compared with SP-B-T or WT, SP-B-C exhibited lower SP-B, higher NF-κB and NLRP3 inflammasome activation, and higher activated caspase-3.
CONCLUSIONS: hSP-B variants differentially regulate susceptibility through modulating the surface activity of surfactant, cell death, and inflammatory signaling in sepsis.
参考来源
- Yang F, Zhang J, Yang Y, et al. Regulatory Roles of Human Surfactant Protein B Variants on Genetic Susceptibility to Pseudomonas Aeruginosa Pneumonia-Induced Sepsis. Shock. 2020. PMID: 31851120. doi:10.1097/SHK.0000000000001494
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。